PRINTER'S NO. 2967
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
2047
Session of
2018
INTRODUCED BY ROZZI, KINSEY, CALTAGIRONE, MILLARD, HARKINS,
DAVIS AND COX, JANUARY 31, 2018
REFERRED TO COMMITTEE ON HEALTH, JANUARY 31, 2018
AN ACT
Amending the act of October 27, 2014 (P.L.2911, No.191),
entitled "An act providing for prescription drug monitoring;
creating the ABC-MAP Board; establishing the Achieving Better
Care by Monitoring All Prescriptions Program; and providing
for unlawful acts and penalties," further providing for
definitions.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. The definition of "controlled substance" in
section 3 of the act of October 27, 2014 (P.L.2911, No.191),
known as the Achieving Better Care by Monitoring All
Prescriptions Program (ABC-MAP) Act, is amended to read:
Section 3. Definitions.
The following words and phrases when used in this act shall
have the meanings given to them in this section unless the
context clearly indicates otherwise:
* * *
"Controlled substance." A drug, substance or immediate
precursor included in the act of April 14, 1972 (P.L.233,
No.64), known as The Controlled Substance, Drug, Device and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Cosmetic Act, or the Controlled Substances Act (Public Law 91-
513, 84 Stat. 1236). The term includes naltrexone or another
nonnarcotic, nonaddictive drug used in medication-assisted
treatment for opioid or alcohol use disorders, whether in pill
form or injectable form.
* * *
Section 2. This act shall take effect in 60 days.
20180HB2047PN2967 - 2 -
1
2
3
4
5
6
7